Effects of the IDH1 R132H Mutation on the Energy Metabolism: A Comparison between Tissue and Corresponding Primary Glioma Cell Cultures

[Image: see text] The R132H mutation in the metabolic enzyme isocitrate dehydrogenase 1 (IDH1) is the most important prognostic factor for the survival of glioma patients. Subsequent studies led to the discovery of a panel of enzymes mainly involved in glutamate anaplerosis and aerobic glycolysis th...

Descripción completa

Detalles Bibliográficos
Autores principales: Dekker, Lennard J. M., Verheul, Cassandra, Wensveen, Nicky, Leenders, William, Lamfers, Martine L. M., Leenstra, Sieger, Luider, Theo M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811756/
https://www.ncbi.nlm.nih.gov/pubmed/35128264
http://dx.doi.org/10.1021/acsomega.1c06121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8811756/
https://www.ncbi.nlm.nih.gov/pubmed/35128264
http://dx.doi.org/10.1021/acsomega.1c06121

Ejemplares similares